Mario Enrico Canonico/LinkedIn
Aug 20, 2026, 13:46
Mario Enrico Canonico։ CLEAR Outcomes Analysis Highlights Bempedoic Acid Benefits in PAD
Mario Enrico Canonico, Assistant Research Professor of Medicine at University of Colorado, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Circulation, adding:
”Excited to share our analysis from the CLEAR Outcomes trial, led by Marc Bonaca, now published in Circulation!
Bempedoic acid reduced MACE and MALE in patients with PAD.”
Title: Bempedoic Acid and First and Recurrent Limb Outcomes in Statin-Intolerant Patients With Peripheral Artery Disease: Insights From the CLEAR Outcomes Trial
Authors: Marc P. Bonaca, Mario Enrico Canonico, Na Li, William J. Sasiela, Steven E. Nissen, A. Michael Lincoff, Stephen J. Nicholls
Stay updated on the latest scientific advances with Hemostasis Today.
-
Aug 20, 2026, 16:13Geraldine Walsh: Exploring Blood Components in Transfusion Today
-
Aug 20, 2026, 16:02José Antonio García Erce: Canada Updates Recommendations on Transfusion and Albumin
-
Aug 20, 2026, 16:01Prashant Mehta: Optimizing Inotuzumab Dosing in B-ALL
-
Aug 20, 2026, 15:56Jecko Thachil: Heavy Menstrual Bleeding – Obstacle for Quality of Life
-
Aug 20, 2026, 15:32Ifeanyichukwu Ifechidere: Protein S Deficiency – When the Timing of the Test Matters
-
Aug 20, 2026, 15:25Giuseppe Leone: Sickle Cell Disease and Transfusion-Dependent β-Thalassemia in Adults
-
Aug 20, 2026, 15:24Glycoprotein-Specific Platelet Autoantibodies in Persistent Chemotherapy – Journal of Thrombosis and Haemostasis
-
Aug 20, 2026, 15:15The Cell in Your Bone Marrow Responsible for Making Platelets – ITP Support Association
-
Aug 20, 2026, 15:10Shiny K. Kajal: The Latest ISBT Blood Group Update Is Here